We are live on
!
Find out more
CM
Crestline Management Portfolio holdings
AUM
$46.3M
1-Year Est. Return
48.82%
This Fund
S&P 500
This Quarter
Est. Return
+14.34%
1 Year Est. Return
+48.82%
3 Year Est. Return
+52.52%
5 Year Est. Return
+37.91%
10 Year Est. Return
+316.44%
AUM
$546M
AUM Growth
+$146M
(+36%)
Cap. Flow
+$94.4M
Cap. Flow
% of AUM
17.28%
Top 10 Holdings %
Top 10 Hldgs %
77.86%
Holding
148
New
66
Increased
27
Reduced
14
Closed
36
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGU
Agrium
AGU
|
+$5.04M |
| 2 |
Dover
DOV
|
+$4.81M |
| 3 |
FedEx
FDX
|
+$4.81M |
| 4 |
Celanese
CE
|
+$4.28M |
| 5 |
Bunge Global
BG
|
+$3.93M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CADE
Cadence Bank
CADE
|
+$2.17M |
| 2 |
Huntington Bancshares
HBAN
|
+$2.12M |
| 3 |
Edwards Lifesciences
EW
|
+$1.82M |
| 4 |
M&T Bank
MTB
|
+$1.72M |
| 5 |
Biogen
BIIB
|
+$1.65M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 9.04% |
| 2 | Financials | 8% |
| 3 | Healthcare | 4.75% |
| 4 | Materials | 3.56% |
| 5 | Technology | 1.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Kornit Digital
KRNT
$705M
| $1.05M | 0.19% |
55,235
-8,521
| -13% | -$140K |
|
52
Cigna
CI
$73.8B
| $1.04M | 0.19% |
+7,100
| New | +$1.05M |
|
53
FMC
FMC
$1.34B
| $1.01M | 0.18% |
+16,719
| New | +$865K |
|
|
GTLS
54
DELISTED
Chart Industries
GTLS
| $1M | 0.18% |
28,739
+21,066
| +275% | +$780K |
|
|
ESPR
55
DELISTED
Esperion Therapeutics
ESPR
| $967K | 0.18% |
+27,400
| New | +$627K |
|
56
Sarepta Therapeutics
SRPT
$1.57B
| $965K | 0.18% |
+32,600
| New | +$1.01M |
|
|
FOLD
57
DELISTED
Amicus Therapeutics
FOLD
| $957K | 0.18% |
+134,200
| New | +$848K |
|
58
Incyte
INCY
$24.2B
| $951K | 0.17% |
7,115
+3,230
| +83% | +$411K |
|
|
TREC
59
DELISTED
Trecora Resources
TREC
| $948K | 0.17% |
85,383
+62,785
| +278% | +$772K |
|
|
STL
60
DELISTED
Sterling Bancorp
STL
| $948K | 0.17% |
+40,000
| New | +$962K |
|
61
DNOW Inc
DNOW
$2.58B
| $943K | 0.17% |
55,593
+8,879
| +19% | +$175K |
|
|
SIVB
62
DELISTED
SVB Financial Group
SIVB
| $930K | 0.17% |
+5,000
| New | +$909K |
|
63
UnitedHealth
UNH
$376B
| $873K | 0.16% |
+5,325
| New | +$872K |
|
64
Texas Capital Bancshares
TCBI
$4.3B
| $835K | 0.15% |
10,000
| – | – |
|
|
FOMX
65
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $819K | 0.15% |
+101,700
| New | +$979K |
|
|
ISBC
66
DELISTED
Investors Bancorp, Inc.
ISBC
| $791K | 0.14% |
+55,000
| New | +$788K |
|
67
Vertex Pharmaceuticals
VRTX
$121B
| $776K | 0.14% |
+7,100
| New | +$625K |
|
|
KDNY
68
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $764K | 0.14% |
+14,220
| New | +$803K |
|
69
Cathay General Bancorp
CATY
$4.22B
| $754K | 0.14% |
+20,000
| New | +$760K |
|
70
Ardelyx
ARDX
$1.22B
| $720K | 0.13% |
+56,900
| New | +$749K |
|
71
VeriSign
VRSN
$26.2B
| $716K | 0.13% |
+8,218
| New | +$683K |
|
72
Fulton Financial
FULT
$4.66B
| $714K | 0.13% |
40,000
-30,000
| -43% | -$556K |
|
73
Broadcom
AVGO
$1.85T
| $640K | 0.12% |
29,230
-13,760
| -32% | -$283K |
|
74
KBR
KBR
$4.64B
| $637K | 0.12% |
+42,400
| New | +$674K |
|
75
GoDaddy
GDDY
$11B
| $629K | 0.12% |
+16,595
| New | +$601K |
|
Similar funds
MCMC
RRC
PCM
NPCM
FCM
EGI
IPHI
SM
Crestline Management's Q1 2017 Portfolio in Review
As of Q1 2017, Crestline Management held 148 positions worth $546M, up 36% from $401M the previous quarter. Its ten largest holdings account for 78% of the portfolio.
Crestline Management deployed $94.4M of net new capital in Q1 2017, opening 66 new positions and adding to 27 existing holdings. Its largest new stake was Agrium: 50,000 shares worth $4.78M.
By sector, the portfolio is most concentrated in Industrials at 9% of assets, up from 2.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Zimmer Biomet, an estimated $1.25M trimmed.
- Crestline Management's largest Q1 2017 buy was Agrium: 50,000 shares worth $4.78M.
- Crestline Management added most to US Bancorp in Q1 2017, an estimated $2.67M increase.
- Crestline Management's biggest Q1 2017 reduction was Zimmer Biomet, cutting an estimated $1.25M.
- Crestline Management fully exited Cadence Bank in Q1 2017, selling an estimated $2.17M.
- Crestline Management's ten largest holdings make up 78% of its $546M portfolio in Q1 2017.
- Crestline Management opened 66 new positions and closed 36 in Q1 2017.
- Crestline Management's portfolio value rose 36% quarter-over-quarter to $546M.
Based on Crestline Management's 13F filing for Q1 2017, filed 12 May 2017.